Trademark applications and grants for Macrogenics Inc. Macrogenics Inc has 37 trademark applications. The latest application filed is for "MACROGENICS"
Patent Application | Date |
---|---|
Covalent Diabodies and Uses Thereof 20220275082 - 17/570530 Johnson; Leslie S. ;   et al. | 2022-09-01 |
Dosing Regimens of Bispecific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies 20220213203 - 17/601787 Davidson; Jan Kenneth ;   et al. | 2022-07-07 |
Combination Therapy for the Treatment of Cancer 20220204625 - 17/479930 Vasselli; James ;   et al. | 2022-06-30 |
Pharmaceutical Compositions of a HER2/neu Antibody and Use of the Same 20220177602 - 17/541926 Farb; David Lee ;   et al. | 2022-06-09 |
FcgammaRIIB-Specific Antibodies and Methods of Use Thereof 20220177574 - 17/377641 Johnson; Leslie S. ;   et al. | 2022-06-09 |
NCAGE Code | 3PTZ3 | MACROGENICS, INC. |
CAGE Code | 3PTZ3 | MACROGENICS, INC. |
S.A.M. Registration | 3PTZ3 [10626351] | MACROGENICS, INC. |
SEC | 0001125345 | MACROGENICS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.